2006: Medipix2
Much like the first x-rays discovered by Wilhelm Röntgen in 1895, the capability of the Medipix detector was first demonstrated on a hand.
2007: MBI was founded
The company was formed in 2007 to commercialize the ground-breaking photon-counting Medipix technology. Four colors could be measured one after the other, not simultaneously. Scanning took one day, reconstruction took one month.
2011: First commercially available multi-energy small-bore scanner for preclinical research
2013: Medipix3
The latest version of the Medipix detector chip was suitable for imaging. MARS Bioimaging Ltd has exclusive rights for Medipix3 developed at CERN in the field of small animal and human CT.
2017: An award winning manufacturer
Ground-breaking work achieved by MBI was recognized at the Champion Canterbury Awards and New Zealand Innovation Awards. MBI began appointing partners for product distribution.
2018: First human image
In 2018, MBI scanned a living human body using the revolutionary ‘color’ CT. The images are the first of its kind captured by the Medipix detector technology.
2019-present: Clinical trials
MBI began human trials in 2019 to assess the value of this technology for evaluating injured wrists. The first trials were based at the University of Canterbury, Christchurch, New Zealand. The preliminary results are very exciting and MBI are motivated to move to the next step. https://marsbioimaging. Sign up to hear about our clinical and technical updates.
（transferred from MBI website）
